BENDAMUSTINE 2.5mg/ml 100mg, 5's

Bendamustine hydrochloride is a medicine which is used for the treatment of certain types of cancer (cytotoxic medicine). Bendamustine hydrochloride is used alone (monotherapy) or in combination with other medicines for the treatment of the following forms of cancer: - chronic lymphocytic leukaemia in cases where fludarabine combination chemotherapy is not appropriate for you, - non-Hodgkin lymphomas, which had not, or only shortly, responded to prior rituximab treatment, - multiple myeloma in cases where thalidomide or bortezomib containing therapy is not appropriate for you.

BICALUTAMIDE 50mg TAB, 28"s

Bicalutamide contains a medicine called bicalutamide. This belongs to a group of medicines called ‘anti-androgens’. • Bicalutamide Teva is used to treat prostrate cancer. • It works by blocking the effects of male hormones such as testosterone.

BORTEZOMIB 3.5mg VIAL, 1's

Bortezomib powder contains the active substance bortezomib, a so-called ‘proteasome inhibitor’. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, bortezomib can kill cancer cells. Bortezomib is used for the treatment of multiple myeloma (a cancer of the bone marrow) in patients older than 18 years: • alone or together with the medicines pegylated liposomal doxorubicin or dexamethasone, for patients whose disease is worsening (progressive) after receiving at least one prior treatment and for whom blood stem cell transplantation was not successful or is unsuitable • in combination with the medicines melphalan and prednisone, for patients whose disease has not been previously treated and are unsuitable for high-dose chemotherapy with blood stem cell transplantation • in combination with the medicines dexamethasone or dexamethasone together with thalidomide, for patients whose disease has not been previously treated and before receiving high-dose chemotherapy with blood stem cell transplantation (induction treatment). Bortezomib is used for the treatment of mantle cell lymphoma (a type of cancer affecting the lymph nodes) in patients 18 years or older in combination with the medicines rituximab, cyclophosphamide, doxorubicin and prednisone, for patients whose disease has not been previously treated and for whom blood stem cell transplantation is unsuitable.

CAPECITABINE 500mg TAB, 120's

Capecitabine Accord belongs to the group of medicines called "cytostatic medicines", which stop the growth of cancer cells. Capecitabine Accord contains capecitabine, which itself is not a cytostatic medicine. Only after being absorbed by the body is it changed into an active anti-cancer medicine (more in tumour tissue than in normal tissue). Capecitabine Accord is used in the treatment of colon, rectal, gastric, or breast cancers. Furthermore, Capecitabine Accord is used to prevent new occurrence of colon cancer after complete removal of the tumour by surgery. Capecitabine Accord may be used either alone or in combination with other medicines.

Docetaxel GP Pharm 20mg

Docetaxel is a chemotherapeutic antimitotic agent that works by interfering with cell division. It is used in the treatment of various types of cancer such as breast, ovarian or prostate. It is available in 2 different strengths: 20 mg and 80 mg.

Docetaxel GP Pharm 80mg

Docetaxel is a chemotherapeutic antimitotic agent that works by interfering with cell division. It is used in the treatment of various types of cancer such as breast, ovarian or prostate. It is available in 2 different strengths: 20 mg and 80 mg.

Doxorubicina Tedec Meiji 10mg

Doxorubicin is used to treat different forms of cancer.

Doxorubicina Tedec Meiji 50mg

Doxorubicina is used to trat different forms of cancer.

EXEMESTANE 25mg TAB, 30's

Exemestane belongs to a group of medicines known as aromatase inhibitors. These medicines interfere with a substance called aromatase, which is needed to make the female sex hormones, oestrogens, especially in postmenopausal women. Reduction in oestrogen levels in the body is a way of treating hormone dependent breast cancer. Exemestane is used to treat hormone dependent early breast cancer in postmenopausal women after they have completed 2-3 years of treatment with the medicine tamoxifen. Exemestane is also used to treat hormone dependent advanced breast cancer in postmenopausal women when a different hormonal drug treatment has not worked well enough.

FINASTERIDE 5mg TAB, 28's

Finasteride belongs to the group of medicines called 5-alpha reductase inhibitors. They act by reducing the size of the prostate gland in men. Finasteride shrinks the prostate gland in men when it is swollen. Finasteride is used in the treatment and control of benign (i.e., non-cancerous) enlargement of the prostate (benign prostatic hyperplasia - BPH). The prostate gland is found underneath the bladder (but only in man). It produces the fluid found in semen. A swollen prostate gland can lead to a condition called ‘benign prostatic hyperplaia’ (BPH). Finasteride causes shrinkage of the enlarged prostate, improves urinary flow and symptoms caused by BPH, and reduces the risk of you developing a sudden inability to pass urine (known as acute urinary retention) and the need for surgery.

FontActiv diaBest HP

For the dietary treatment of patients at risk of malnutrition or those in need of an increased amount of energy and proteins.

FontActiv HP/HC

For the dietary treatment of patients at risk of malnutrition or those in need of an increased amount of energy and proteins.

Gemcitabine GP Pharm 1g

Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer, in combination with cisplatin, and for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.

Gemcitabine GP Pharm 200mg

Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer, in combination with cisplatin, and for the treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.

Grani Denk 1mg/ml - 3mg/3ml

To prevent or treat nausea and vomiting caused by other medical treatments such as chemotherapy or radiotherapy.